Exact Sciences, Biomerica & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Advertisement

Exact Sciences and the American Association of Nurse Practitioners released the results of their HealthyWomen’s National Colorectal Cancer Screening Knowledge and Patient Patterns Survey.

Mark Stenhouse left his executive role at AbbVie to join Exact Sciences because he felt the company was fighting a worthy battle: preventing colorectal cancer.

Biomerica enrolled the first patient in a clinical trial for its InFoods diagnostic-guided therapy to alleviate irritable bowel syndrome symptoms.

OmniVision Technologies and Myriad Fiber developed what they call the medical industry’s first commercial prototype for an endoscopic surgery tool with built-in camera.

More articles on gastroenterology:
Tennova Healthcare nixes hospital services, new ASC in the works — 4 insights
The best advice for your ASC and practice
The Joint Commission revises pain standards for ambulatory care — 6 details

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.